Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Spence

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Neurology|May 1, 1980
Cerebral embolism in Libman-Sacks endocarditisI S Fox, A M Spence, R F Wheelis, et al.
Journal of Neuro-Oncology|January 1, 1987
Blood flow in an experimental rat brain tumor by tissue equilibration and indicator fractionationM M Graham, A M Spence, G L Abbott, et al.
Journal of Neuro-Oncology|February 1, 1992
Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failureA M Spence, M S Berger, R B Livingston, et al.
Radiation Research|September 1, 1988
Blood flow changes following 137Cs irradiation in a rat glioma modelA M Spence, M M Graham, G L Abbott, et al.
Radiation Research|April 1, 1985
Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913)J S Rasey, Z Grunbaum, K A Krohn, et al.
Molecular Biology of the Cell|October 12, 2000
The diabetes autoantigen ICA69 and its Caenorhabditis elegans homologue, ric-19, are conserved regulators of neuroendocrine secretionM Pilon, X R Peng, A M Spence, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Radioprotection in rat spinal cord with WR-2721 following cerebral lateral intraventricular injectionA M Spence, K A Krohn, S W Edmondson, et al.
Lancet (London, England)|February 11, 1978
Myotonic dystrophy, mitral-valve prolapse, and strokeA W Cook, T D Bird, A M Spence, et al.
Pharmacology & Therapeutics|January 1, 1988
WR-2721, WR-77913 and WR-3689 radioprotection in the rat spinal cordA M Spence, K A Krohn, J E Steele, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1997
Corpus callosum involvement as a prognostic factor for patients with high-grade astrocytomaK J Steltzer, K I Sauvé, A M Spence, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Neurology|May 1, 1980
Cerebral embolism in Libman-Sacks endocarditisI S Fox, A M Spence, R F Wheelis, et al.
Journal of Neuro-Oncology|January 1, 1987
Blood flow in an experimental rat brain tumor by tissue equilibration and indicator fractionationM M Graham, A M Spence, G L Abbott, et al.
Journal of Neuro-Oncology|February 1, 1992
Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failureA M Spence, M S Berger, R B Livingston, et al.
Radiation Research|September 1, 1988
Blood flow changes following 137Cs irradiation in a rat glioma modelA M Spence, M M Graham, G L Abbott, et al.
Radiation Research|April 1, 1985
Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913)J S Rasey, Z Grunbaum, K A Krohn, et al.
Molecular Biology of the Cell|October 12, 2000
The diabetes autoantigen ICA69 and its Caenorhabditis elegans homologue, ric-19, are conserved regulators of neuroendocrine secretionM Pilon, X R Peng, A M Spence, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Radioprotection in rat spinal cord with WR-2721 following cerebral lateral intraventricular injectionA M Spence, K A Krohn, S W Edmondson, et al.
Lancet (London, England)|February 11, 1978
Myotonic dystrophy, mitral-valve prolapse, and strokeA W Cook, T D Bird, A M Spence, et al.
Pharmacology & Therapeutics|January 1, 1988
WR-2721, WR-77913 and WR-3689 radioprotection in the rat spinal cordA M Spence, K A Krohn, J E Steele, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1997
Corpus callosum involvement as a prognostic factor for patients with high-grade astrocytomaK J Steltzer, K I Sauvé, A M Spence, et al.
Pageof 9